The Get Outside Study (GO)
26 de julho de 2022 atualizado por: Stephanie Anzman-Frasca, State University of New York at Buffalo
Examining Adults' Activity Choices During COVID-19: The UB GO Study
The primary aim of this study is to examine whether lower-risk activities displace participation in higher-risk behaviors during COVID-19.
Investigators will test this aim by promoting specific activities that are expected to be low-risk when it comes to COVID-19 transmission (e.g., participating in a hiking challenge) and assessing impacts on participants' activity choices.
Investigators also aim to describe adults' activity participation during COVID-19 generally and to examine secondary outcomes, including reported stress and sleep.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
The primary aim of this study is to examine whether lower-risk activities displace participation in higher-risk behaviors during COVID-19. Investigators will test this aim by promoting specific activities that are expected to be low-risk when it comes to COVID-19 transmission and assessing impacts on participants' activity choices.
There will be two study groups, Group 1 and Group 2, each of which will complete 3 online surveys and will be provided with information on lower-risk activities to do during COVID-19. Random assignment to groups will occur after the completion of a baseline survey. Group 1 will receive free access to a local hiking challenge after completing their baseline survey and an information sheet with current CDC-recommended activities after post-test. Group 2 will receive the same resources, but in the opposite order. Therefore, surveys administered at midpoint (~6 weeks) and post-test (~12 weeks) will allow for a test of the effects of providing access to the hiking challenge on outcomes of interest.
If participants choose to sign up for the hiking challenge, they receive a list of local hikes/nature walks, accompanying maps, scavenger-hunt-like activities (finding a certain landmark on each hike), and the opportunity to earn prizes and engage with other hikers on social media. The primary outcome will be the activities in which participants engage. An adapted version of the Pleasant Activities list (Koks) will be used to assess activities participants have engaged in during the past 30 days at baseline, midpoint (~6 weeks), and post-test (~12 weeks). Current CDC guidance will be used to code activities as lower- and higher-risk anticipating the creation of an aggregate frequency of activities in each of the following categories: activities done outdoors alone or with members of the household (lower risk), activities done indoors alone or with members of the household (lower risk), activities done outdoors with others not in one's household (moderate risk), and activities done indoors with others not in one's household (higher risk). Adults' participation in different types of activities will also be summarized generally, in addition to specific activities of interest (e.g., the lower risk activities that are being targeted, like hiking; and activities that have received attention as being particularly higher risk, like indoor restaurant dining). Investigators will also examine impacts of the provision of the hiking challenge on secondary outcomes, including reported stress and sleep.
The study has the potential to shed light on displacement of higher-risk activities through promotion of lower-risk activities that could serve as substitutes. It also allows for an assessment of the impacts of the local hiking challenge on aspects of well-being. The first cohort of data collection for this study took place between January 2021-April 2021. A replication study was conducted in January 2022-April 2022. The details of the replication study were nearly identical, with one change being the provision of hiking equipment valued at ~$25 (microspikes for the Hiking Challenge intervention group and hiking socks for Activity List controls/the delayed intervention), a modification made based on barriers reported in the original study.
Tipo de estudo
Intervencional
Inscrição (Real)
53
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
New York
-
Buffalo, New York, Estados Unidos, 14214
- State University of New York at Buffalo
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
18 anos e mais velhos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Sim
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- 18 years of age or older
- English speaking
- Has online access
- Reports living in Western New York
- Interested in receiving "suggestions for ways to get outside, stay active, and stay busy" during COVID-19
- No health problems that preclude participation
- Not currently involved in regular (at least weekly) hikes/nature walks
Exclusion Criteria:
- Is under 18 years of age
- Not English speaking
- Does not have online access
- Does not report living in Western New York
- Is not interested in "suggestions for ways to get outside, stay active, and stay busy" during COVID-19
- Has health problems precluding participation
- Is currently involved in regular hikes/nature walks
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Hiking Challenge
This group receives access to the local hiking challenge after completion of baseline measure
|
The main intervention of interest is the provision of free access to a local hiking challenge (which is provided following baseline assessments in the experimental group and after the conclusion of the study in the control group; $20 value).
If participants choose to sign up for the free hiking challenge, they receive a list of local hikes/nature walks, accompanying maps, scavenger-hunt-like activities (finding a certain landmark on each hike), and the opportunity to earn prizes and engage with other hikers on social media.
|
|
Comparador Ativo: Activity list
This group receives access to a resource sheet with activity ideas after completion of baseline measure and does not receive the main resource of interest (hiking challenge) until after the post-test (delayed intervention)
|
The control group will receive a list of CDC-recommended activities following the baseline survey and will receive the hiking challenge as a delayed intervention following post-test.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Frequency of lower-risk activities
Prazo: Post-test (12 weeks)
|
Participants will indicate the frequency that they complete various activities using an adapted version of the Pleasant Activities List (Koks).
Frequencies of each activity are indicated on a 0-4 scale where 0=never in the past 30 days and 4=very often in the past 30 days/more than 1 time per week.
For each activity, participants will also indicate if it was done indoors or outdoors and who was there.
We will aggregate the frequencies of activities that are lower-risk for COVID-19 transmission based on CDC recommendations at the time of the study.
We anticipate that two indicators of lower-risk activities will be those completed outdoors by oneself or with individuals in the household and those completed indoors in which only the self or those in the household are present.
|
Post-test (12 weeks)
|
|
Frequency of higher-risk activities
Prazo: Post-test (12 weeks)
|
Participants will indicate the frequency that they complete various activities using an adapted version of the Pleasant Activities List (Koks).
Frequencies of each activity are indicated on a 0-4 scale where 0=never in the past 30 days and 4=very often in the past 30 days/more than 1 time per week.
For each activity, participants will also indicate if it was done indoors or outdoors and who was there.
We will aggregate the frequencies of activities that are higher-risk for COVID-19 transmission based on CDC recommendations at the time of the study.
We anticipate that two indicators of moderate- or high-risk activities will be those completed outdoors with individuals who do not live in one's household (moderate) and those completed indoors with individuals who do not live in one's household (high).
|
Post-test (12 weeks)
|
|
Frequency of social activities
Prazo: Post-test (12 weeks)
|
Participants will indicate the frequency that they complete various activities using an adapted version of the Pleasant Activities List (Koks).
Frequencies of each activity are indicated on a 0-4 scale where 0=never in the past 30 days and 4=very often in the past 30 days/more than 1 time per week.
For each activity, participants will also indicate if it was done indoors or outdoors and who was there.
We will aggregate the frequencies of activities that are social, both those done with members of the household as well as those done with individuals who do not live in the household with the participant
|
Post-test (12 weeks)
|
|
Frequency of physical activities
Prazo: Post-test (12 weeks)
|
Participants will indicate the frequency that they complete various activities using an adapted version of the Pleasant Activities List (Koks).
Frequencies of each activity are indicated on a 0-4 scale where 0=never in the past 30 days and 4=very often in the past 30 days/more than 1 time per week.
For each activity, participants will also indicate if it was done indoors or outdoors and who was there.
We will aggregate the frequencies of activities that involve physical activity (e.g., walks, hikes, sports)
|
Post-test (12 weeks)
|
|
Frequency of hiking/nature walks
Prazo: Post-test (12 weeks)
|
Participants will indicate the frequency that they complete various activities using an adapted version of the Pleasant Activities List (Koks).
Frequencies of each activity are indicated on a 0-4 scale where 0=never in the past 30 days and 4=very often in the past 30 days/more than 1 time per week.
For each activity, participants will also indicate if it was done indoors or outdoors and who was there.
We will examine the frequency indicated for the item: Going on a hike or nature walk
|
Post-test (12 weeks)
|
|
Frequency of restaurant dining
Prazo: Post-test (12 weeks)
|
Participants will indicate the frequency that they complete various activities using an adapted version of the Pleasant Activities List (Koks).
Frequencies of each activity are indicated on a 0-4 scale where 0=never in the past 30 days and 4=very often in the past 30 days/more than 1 time per week.
For each activity, participants will also indicate if it was done indoors or outdoors and who was there.
We will examine the frequency indicated for the item: Going to a restaurant or café / eating out
|
Post-test (12 weeks)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Stress
Prazo: Post-test (12 weeks)
|
The 10-item perceived stress scale will be used to assess stress over the past month.
Each item is scored from 0-4, for a total possible score of 0-40 (higher score = more stress).
|
Post-test (12 weeks)
|
|
Sleep
Prazo: Post-test (12 weeks)
|
Total nighttime sleep time will come from the Pittsburgh Sleep Quality Index (hours).
|
Post-test (12 weeks)
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Frequency of lower-risk activities
Prazo: Midpoint (6 weeks)
|
Participants will indicate the frequency that they complete various activities using an adapted version of the Pleasant Activities List (Koks).
Frequencies of each activity are indicated on a 0-4 scale where 0=never in the past 30 days and 4=very often in the past 30 days/more than 1 time per week.
For each activity, participants will also indicate if it was done indoors or outdoors and who was there.
We will aggregate the frequencies of activities that are lower-risk for COVID-19 transmission based on CDC recommendations at the time of the study.
We anticipate that two indicators of lower-risk activities will be those completed outdoors by oneself or with individuals in the household and those completed indoors in which only the self or those in the household are present.
|
Midpoint (6 weeks)
|
|
Frequency of lower-risk activities
Prazo: Change from baseline to post-test (12 weeks)
|
Participants will indicate the frequency that they complete various activities using an adapted version of the Pleasant Activities List (Koks).
Frequencies of each activity are indicated on a 0-4 scale where 0=never in the past 30 days and 4=very often in the past 30 days/more than 1 time per week.
For each activity, participants will also indicate if it was done indoors or outdoors and who was there.
We will aggregate the frequencies of activities that are lower-risk for COVID-19 transmission based on CDC recommendations at the time of the study.
We anticipate that two indicators of lower-risk activities will be those completed outdoors by oneself or with individuals in the household and those completed indoors in which only the self or those in the household are present.
|
Change from baseline to post-test (12 weeks)
|
|
Frequency of higher-risk activities
Prazo: Midpoint (6 weeks)
|
Participants will indicate the frequency that they complete various activities using an adapted version of the Pleasant Activities List (Koks).
Frequencies of each activity are indicated on a 0-4 scale where 0=never in the past 30 days and 4=very often in the past 30 days/more than 1 time per week.
For each activity, participants will also indicate if it was done indoors or outdoors and who was there.
We will aggregate the frequencies of activities that are higher-risk for COVID-19 transmission based on CDC recommendations at the time of the study.
We anticipate that two indicators of moderate- or high-risk activities will be those completed outdoors with individuals who do not live in one's household (moderate) and those completed indoors with individuals who do not live in one's household (high).
|
Midpoint (6 weeks)
|
|
Frequency of higher-risk activities
Prazo: Change from baseline to post-test (12 weeks)
|
Participants will indicate the frequency that they complete various activities using an adapted version of the Pleasant Activities List (Koks).
Frequencies of each activity are indicated on a 0-4 scale where 0=never in the past 30 days and 4=very often in the past 30 days/more than 1 time per week.
For each activity, participants will also indicate if it was done indoors or outdoors and who was there.
We will aggregate the frequencies of activities that are higher-risk for COVID-19 transmission based on CDC recommendations at the time of the study.
We anticipate that two indicators of moderate- or high-risk activities will be those completed outdoors with individuals who do not live in one's household (moderate) and those completed indoors with individuals who do not live in one's household (high).
|
Change from baseline to post-test (12 weeks)
|
|
Frequency of hiking/nature walks
Prazo: Midpoint (6 weeks)
|
Participants will indicate the frequency that they complete various activities using an adapted version of the Pleasant Activities List (Koks).
Frequencies of each activity are indicated on a 0-4 scale where 0=never in the past 30 days and 4=very often in the past 30 days/more than 1 time per week.
For each activity, participants will also indicate if it was done indoors or outdoors and who was there.
Here we will examine responses to the item about the frequency of hiking or nature walks.
|
Midpoint (6 weeks)
|
|
Frequency of hiking/nature walks
Prazo: Change from baseline to post-test (12 weeks)
|
Participants will indicate the frequency that they complete various activities using an adapted version of the Pleasant Activities List (Koks).
Frequencies of each activity are indicated on a 0-4 scale where 0=never in the past 30 days and 4=very often in the past 30 days/more than 1 time per week.
For each activity, participants will also indicate if it was done indoors or outdoors and who was there.
Here we will examine responses to the item about the frequency of hiking or nature walks.
|
Change from baseline to post-test (12 weeks)
|
|
Stress
Prazo: Midpoint (6 weeks)
|
The 10-item perceived stress scale will be used to assess stress over the past month.
Each item is scored from 0-4, for a total possible score of 0-40 (higher score = more stress).
|
Midpoint (6 weeks)
|
|
Stress
Prazo: Change from baseline to post-test (12 weeks)
|
The 10-item perceived stress scale will be used to assess stress over the past month.
Each item is scored from 0-4, for a total possible score of 0-40 (higher score = more stress).
|
Change from baseline to post-test (12 weeks)
|
|
Sleep
Prazo: Midpoint (6 weeks)
|
Total nighttime sleep time will come from the Pittsburgh Sleep Quality Index (hours).
|
Midpoint (6 weeks)
|
|
Sleep
Prazo: Change from baseline to post-test (12 weeks)
|
Total nighttime sleep time will come from the Pittsburgh Sleep Quality Index (hours).
|
Change from baseline to post-test (12 weeks)
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
7 de janeiro de 2021
Conclusão Primária (Real)
25 de março de 2022
Conclusão do estudo (Real)
25 de março de 2022
Datas de inscrição no estudo
Enviado pela primeira vez
7 de dezembro de 2020
Enviado pela primeira vez que atendeu aos critérios de CQ
22 de dezembro de 2020
Primeira postagem (Real)
28 de dezembro de 2020
Atualizações de registro de estudo
Última Atualização Postada (Real)
29 de julho de 2022
Última atualização enviada que atendeu aos critérios de controle de qualidade
26 de julho de 2022
Última verificação
1 de julho de 2022
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- STUDY00005101
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .